Should I buy shares in Sophos Group?

Shares in growth stock Sophos Group plc (LON: SOPH) are way down from their peak, so is it time to buy?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since flotation in 2015, shares in cloud-based internet security specialist Sophos Group (LSE: SOPH) have gained 60%, while the FTSE 100 has managed 7%.

That’s a good result, but it hides a very volatile ride along the way. After really going nowhere for a couple of years, the shares took off in early 2017, and less than a year later were trading at three times their flotation price.

Sophos had all the hallmarks of a bandwagon stock, which growth investors jump on and buy purely because it’s going up, and the inevitable happened. The shares went into a slide, and even though 2019 has so far seen another bullish rise, those who were unfortunate enough to buy in at the peak are still sitting on a 40% loss in a little over 18 months.

Hot growth stock

To say the P/E valuation of Sophos shares became overheated seems like an understatement, with that multiple reaching around 170 in 2018. That was just before earnings per share more than trebled in 2019, mind, and the combined effect of that rise along with the share price fall has dropped today’s forward P/E to 34.

To me, that’s still a demanding growth valuation, and right now there isn’t too much short-term growth on the cards, with analysts forecasting a small EPS drop this year followed by an 18% rise next.

First-quarter revenue rose by a modest 3%, with billings up 5%. Adjusted operating profit gained 10%, and Sophos recorded impressive cash flow of $54.4m, so business is moving reasonably well.

But it seems to me that Sophos shares soared on the buzzwords of ‘internet’, ‘cloud’ and ‘security’. And while there is a growing market in that business and Sophos undoubtedly offers top-line services, I can’t help thinking the shares need a further downrating to make their valuation attractive.

Another growth bubble?

I’ve been meaning to examine AJ Bell (LSE: AJB) ever since the investment platform provider made its market debut in December. I’m a regular user of the company’s Dividend Dashboard, which is released quarterly and examines the overall dividend picture painted by FTSE 100 forecasts, but I hadn’t delved deeper.

One of my investment rules is to never buy at flotation, mainly because they’re priced and timed to try to raise the most cash for a company’s private owners rather than to provide punters with a bargain opportunity. In following that rule, I’ve missed out on the 70% rise that less cautious investors have enjoyed. But what I ask myself now is whether that’s just more ‘new growth stock’ over-enthusiasm that will soon fall back, or whether it represents a rational and sustainable valuation.

Growth

AJ Bell’s Q3 update reported a 5% rise in customer numbers, and a 13% jump in assets under administration over the past year to push the total above the £50bn mark, at £50.7bn. I’m pleased to read that net inflows of £1bn suggest that investors are taking advantage of the Footsie’s current turmoil, and they benefited from £1.6bn in favourable market movements.

The big problem is that, though forecasts are a bit thin on the ground at this stage in AJ Bell’s life as a public company, what we do have suggests forward P/E multiples in the 60s. There’s surely room for growth, but I see this as another overheated valuation and I expect the bubble to burst.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »